Norpace (G.D. Searle LLC Division of Pfizer Inc)
Welcome to the PulseAid listing for the Norpace drug offered from G.D. Searle LLC Division of Pfizer Inc. This Antiarrhythmic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | G.D. Searle LLC Division of Pfizer Inc |
| NON-PROPRIETARY NAME: | disopyramide phosphate |
| SUBSTANCE NAME: | DISOPYRAMIDE PHOSPHATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Antiarrhythmic [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, GELATIN COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1977-09-01 |
| END MARKETING DATE: | 0000-00-00 |
Norpace HUMAN PRESCRIPTION DRUG Details:
| Item Description | Norpace from G.D. Searle LLC Division of Pfizer Inc |
| LABELER NAME: | G.D. Searle LLC Division of Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 1977-09-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0025-2752_234e0244-3072-4717-9de9-026d6e1f0642 |
| PRODUCT NDC: | 0025-2752 |
| APPLICATION NUMBER: | NDA017447 |
Other DISOPYRAMIDE PHOSPHATE Pharmaceutical Manufacturers / Labelers:
